International journal of surgery (London, England)
Neoadjuvant tislelizumab with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma.
Peng Jin, Wenfeng Yang, Yongsheng Gao, Zheng Fu, Lu Wang, Leyan Cao, Xue Meng
Published: 202510.1097/JS9.0000000000003922
Abstract
BACKGROUND: Combining neoadjuvant immunotherapy with chemoradiotherapy may improve outcomes in esophageal cancer; however, factors underlying its effectiveness remain unclear. This study evaluated the efficacy of neoadjuvant tislelizumab combined wit…
Preview only. Read the full abstract at the source